Bortezomib (PS-341) in patients with human herpesvirus 8-associated primary effusion lymphoma

British Journal of Haematology

Volumn 141, Issue 4, 2008, Pages 559-561

  Boulanger, Emmanuelle ^a   Meignin, Véronique ^b   Oksenhendler, Eric ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Bortezomib; Human herpesvirus 8; Human immunodeficiency virus type 1; Non Hodgkin lymphoma; Primary effusion lymphoma

Indexed keywords

ARSENIC TRIOXIDE; BORTEZOMIB; CIDOFOVIR; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; RAPAMYCIN; ZIDOVUDINE;

CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; LETTER; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC AGENTS; BORONIC ACIDS; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, PRIMARY EFFUSION; MALE; MIDDLE AGED; PYRAZINES;

EID: 42249099305     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07057.x     Document Type: Letter

References (8)

1. Abou-Merhi, R., Khoriaty, R., Arnoult, D., El Hajj, H., Dbouk, H., Munier, S., El-Sabban, M.E., Hermine, O., Gessain, A., de The, H., Mahieux, R. Bazarbachi, A. (2007) PS-341 or a combination of arsenic trioxide and interferon-alpha inhibit growth and induce caspase-dependent apoptosis in KSHV/HHV-8-infected primary effusion lymphoma cells. Leukemia, 21, 1792 1801.
2. An, J., Sun, Y., Fisher, M. Rettig, M.B. (2004) Antitumor effects of bortezomib (PS-341) on primary effusion lymphomas. Leukemia, 18, 1699 1704.
3. Boulanger, E., Gerard, L., Gabarre, J., Molina, J.M., Rapp, C., Abino, J.F., Cadranel, J., Chevret, S. Oksenhendler, E. (2005) Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS. Journal of Clinical Oncology, 23, 4372 4380.
4. Keller, S.A., Schattner, E.J. Cesarman, E. (2000) Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood, 96, 2537 2542.
5. Lee, R.K., Cai, J.P., Deyev, V., Gill, P.S., Cabral, L., Wood, C., Agarwal, R.P., Xia, W., Boise, L.H., Podack, E. Harrington, Jr., W.J. (1999) Azidothymidine and interferon-alpha induce apoptosis in herpesvirus-associated lymphomas. Cancer Research, 59, 5514 5520.
6. Luppi, M., Trovato, R., Barozzi, P., Vallisa, D., Rossi, G., Re, A., Ravazzini, L., Potenza, L., Riva, G., Morselli, M., Longo, G., Cavanna, L., Roncaglia, R. Torelli, G. (2005) Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir. Leukemia, 19, 473 476.
7. Matta, H. Chaudhary, P.M. (2005) The proteasome inhibitor bortezomib (PS-341) inhibits growth and induces apoptosis in primary effusion lymphoma cells. Cancer Biol Ther, 4, 77 82.
8. Sin, S.H., Roy, D., Wang, L., Staudt, M.R., Fakhari, F.D., Patel, D.D., Henry, D., Harrington, Jr., W.J., Damania, B.A. Dittmer, D.P. (2007) Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling. Blood, 109, 2165 2173.